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RESEARCH ARTICLE
Mechanisms of Renal Electrolyte Transport and Ion Channel Regulation in Honor of Dr. Gerhard
Giebisch
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Abstract
The physiological role of the shorter isoform of with no lysine kinase (WNK)1 that is exclusively expressed in the kidney (KS-WNK1),
with particular abundance in the distal convoluted tubule, remains elusive. KS-WNK1, despite lacking the kinase domain, is neverthe-
less capable of stimulating the NaCl cotransporter, apparently through activation of WNK4. It has recently been shown that a less
severe form of familial hyperkalemic hypertension featuring only hyperkalemia is caused by missense mutations in the WNK1 acidic
domain that preferentially affect cullin 3 (CUL3)-Kelch-like protein 3 (KLHL3) E3-induced degradation of KS-WNK1 rather than that of
full-length WNK1. Here, we show that full-length WNK1 is indeed less impacted by the CUL3-KLHL3 E3 ligase complex compared with
KS-WNK1. We demonstrated that the unique 30-amino acid NH2-terminal fragment of KS-WNK1 is essential for its activating effect on
the NaCl cotransporter and recognition by KLHL3. We identified specific amino acid residues in this region critical for the functional
effect of KS-WNK1 and KLHL3 sensitivity. To further explore this, we generated KLHL3-R528H knockin mice that mimic human muta-
tions causing familial hyperkalemic hypertension. These mice revealed that the KLHL3 mutation specifically increased expression of
KS-WNK1 in the kidney. We also observed that in wild-type mice, the expression of KS-WNK1 was only detectable after exposure to a
low-Kþ diet. These findings provide new insights into the regulation and function of KS-WNK1 by the CUL3-KLHL3 complex in the dis-
tal convoluted tubule and indicate that this pathway is regulated by dietary Kþ levels.
NEW & NOTEWORTHY In this work, we demonstrated that the kidney-specific isoform of with no lysine kinase 1 (KS-WNK1) in
the kidney is modulated by dietary Kþ and activity of the ubiquitin ligase protein Kelch-like protein 3. We analyzed the role of
different amino acid residues of KS-WNK1 in its activity against the NaCl cotransporter and sensitivity to Kelch-like protein 3.
distal convoluted tubule; hypertension; salt transport; STE20/SPS1-related proline-alanine-rich protein kinase; with no lysine kinase 4
INTRODUCTION
Familial hyperkalemic hypertension (FHHt) encompasses a
spectrum of diseases that aremainly the consequence of over-
activity of the renal thiazide-sensitive NaCl cotransporter
(NCC) of the distal convoluted tubule (DCT) (1). NCC activity
is modulated by with no lysine kinase (WNK)1 and WNK4,
whose half-life is, in turn, regulated by the cullin–RING E3
ligase complex containing Kelch-like protein 3 (KLHL3) and
cullin 3 (CUL3) proteins. The severity of FHHt depends on
which one of these genes is affected and is defined by age of
diagnosis, Kþ levels, blood pressure levels, and percentage of
affected individuals with hypertension before the age of 18 yr
old. The more severe disease presentation is due to exon 9 de-
letion of CUL3, followed by dominant or recessive mutations
in KLHL3 (2, 3). These mutations impair the ubiquitylation
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and degradation of WNK kinases in the DCT. Less severe is
FHHt due to missense mutations in the acidic motif of
WNK4, which constitutes the recognition site for KLHL3 (4, 5)
and thus abrogate only WNK4 ubiquitylation (6). Finally, the
mildest form of FHHt is due to intronic deletions in theWNK1
gene that apparently result in ectopic expression of the full-
length catalytic isoform of this kinase (known as L-WNK1) in
the DCT (7). Louis-Dit-Picard et al. (8) have recently described,
however, an even milder form of FHHt. In this work, humans
and mice with heterozygous mutations in the acidic domain
of WNK1 display an inherited phenotype with hyperkalemia,
hyperchloremia, and metabolic acidosis, but without arterial
hypertension, that is nevertheless accompanied by low renin
expression levels, suggesting a mild volume expansion that is,
however, not enough to produce hypertension.
The major product of the WNK1 gene in the kidney is a
shorter isoform known as kidney-specific WNK1 (KS-WNK1)
(9–11). This isoform is transcribed from an alternative promoter
located between exons 4 and 4a that lacks the kinase domain
and contains a unique 30-amino acid residues sequence
encoded by exon 4a. Despite lacking a kinase domain, recent
evidence suggests that KS-WNK1 may function as an activator
of NCC. First, in Xenopus laevis oocytes, we have shown that
KS-WNK1 is able to induce phosphorylation and activation of
NCC by interacting with other WNKs and reducing its sensitiv-
ity to Cl. For instance, in the presence of KS-WNK1, WNK4 is
active at higher levels of intracellular Cl concentration,
increasing the activity of the intermediate kinase, STE20/SPS1-
related proline-alanine-rich protein kinase (SPAK), toward
NCC (12). Second, it has been observed that under conditions
in which NCC activity is expected to be increased, like in
response to low dietary Kþ , conglomerations of WNKs, known
as WNK bodies, are formed in DCT cells, and their formation
requires the presence of KS-WNK1 (13, 14), also supporting that
KS-WNK1 is associated with activation of NCC. Third, Louis-
Dit-Picard et al. (8) suggested that the FHHt phenotype
observed in patients with mutations in the acidic domain
of WNK1 is likely due to increased protein expression of
KS-WNK1 in DCT cells because it was observed that the
sensitivity of KS-WNK1 to the CUL3-KLHL3 E3 ligase com-
plex is several times higher than that of L-WNK1 and, thus,
mutations of the acidic motif in WNK1 seem to preferen-
tially protect KS-WNK1 from ubiquitylation by the CUL3-
KLHL3 E3 ligase complex.
Given that both KS-WNK1 and L-WNK1 contain the acidic
motif involved in KLHL3 binding, the different sensitivity to
CUL3-KLHL3 E3 ligase complex-mediated degradation is
surprising. Our goal in the present study was to analyze and
characterize the effect of the CUL3-KLHL3 E3 ligase complex
on KS-WNK1 and to define the protein domains responsible
for the difference in sensitivity. In addition, we began to
explore the physiological stimuli that regulate KS-WNK1 pro-
tein expression levels bymodulating its targeting to degrada-
tion by the CUL3-KLHL3 E3 complex.
METHODS
Generation of KLHL3þ /R528H Mice
KLHL3þ /R528H knockin mice were generated through ho-
mologous recombination strategies by TaconicArtemis
(https://www.taconic.com/). For vector construction, mouse
genomic fragments (obtained from the C57BL/6J RPCIB-731
BAC library) and selected features (such as desired point
mutation, recombination sites, and selection markers, as pro-
vided in Supplemental Fig. S1; see https:/doi.org/10.6084/m9.
figshare.13721791) were assembled into the targeting vector.
The linearized vector was transfected into the
TaconicArtemis C57BL/N Tac embryonic stem (ES) cell line.
Homologous recombinant clones were isolated using positive
(PuroR) and negative [thymidine kinase (TK)] selection.
Specific ES clones were selected by Southern blot analysis of
genomic DNA. Blastocysts were isolated from the uterus of
pregnant BALB/c females at day postcoitum 3.5 and injected
with 10–15 targeted C57BL/6NTac ES cells. After recovery,
eight injected blastocysts were transferred to each uterine
horn of 2.5 days postcoitum, pseudopregnant Naval Medical
Research Institute (NMRI) females. Chimerism was measured
in chimeras (G0) by coat color contribution of ES cells to the
BALB/c host (black/white). Highly chimeric mice were bred to
C57BL/6-Tg(CAG-Flpe)2 Arte females for elimination of the
puromycin resistance cassette. This produced mice that con-
stitutively express mutated KLHL3 protein. The remaining
FRT recombination site in these mice is located in a noncon-
served region of the genome. Primers 6560_31 (50-CACTG-
TGTTCTGCCTTTCAGG-30) and 6560_32 (50-CAGACCAAGAC-
CAGAGAGAAGG-30) were used to confirm the presence of the
R528H mutation by PCR amplification and product
sequencing.
For genotyping analysis, genomic DNA was extracted from
tail biopsies and analyzed by PCR. Primer 1 (50-GATA-
CCCACTGGCATTTGG-30) and primer 2 (50-GGTAAGGGCAG-
CATTACTGG-30) were used to detect wild-type and knockin al-
leles. The wild-type allele generates a 308-bp product, whereas
the knockin allele generates a 383-bp product. The latter prod-
uct is larger due to the presence of the FRT site and flanking
region that remains in an intronic region following Flp-medi-
ated excision of the puromycin selection cassette.
Generation of KLHL3R528H/R528H/KS-WNK1/ Mice
KS-WNK1/ mice were a kind gift from Hadchouel (15)
(INSERM Paris), and the generation and genotyping have been
described in the supporting information of the cited article.
Mice were crossed with of KLHL3þ /R528H to produce the
desired genotypes: wild type, KLHL3R528H/R528H, KS-WNK1/,
and KLHL3R528H/R528H/KS-WNK1/. Male mice were used for
experimental purposes.
Low-Kþ Diet Experiments
Wild-type and KLHL3þ /R528H mice were placed on normal
(1% Kþ ) or Kþ -deficient diets (0.0% Kþ ) for 4 days. The
OpenStandard diet with no added Kþ (D16120202) was pur-
chased from Research Diets and used as the Kþ -deficient
diet. The normal-Kþ diet was prepared by adding KCl. By the
end of the 4-day period, mice were euthanized under isoflur-
ane anesthesia, and kidney samples were collected.
Western Blot Analysis of Mouse Kidney Proteins
Kidney lysates were prepared with lysis buffer containing
50 mM Tris-HCl (pH 7.5), 1 mM EGTA, 1 mM EDTA, 50 mM
sodium fluoride, 5 mM sodium pyrophosphate, 1 mM
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sodium orthovanadate, 1% (w/v) Nonidet P-40, 0.27 M su-
crose, 0.1% (v/v) 2-mercaptoethanol, and protease inhibitors
(1 tablet per 50 mL). Lysates (20 mg) in SDS sample buffer
were subjected to electrophoresis on polyacrylamide gels
and transferred to nitrocellulose membranes. Membranes
were incubated for 30 min with Tris-buffered saline-Tween
20 (TBS-T) containing 5% (w/v) skim milk. Membranes were
then immunoblotted in 5% (w/v) skim milk in TBS-T with
the indicated primary antibodies overnight at 4C. Sheep
antibodies were used at a concentration of 1–2 mg/mL. The
incubation with phospho-specific sheep antibodies was per-
formed with the addition of 10 mg/mL of the dephospho-pep-
tide antigen used to raise the antibody. Blots were thenwashed
six times with TBS-T and incubated for 1 h at room tempera-
ture with secondary horseradish peroxidase (HRP)-conjugated
antibodies diluted 5,000-fold in 5% (w/v) skim milk in TBS-T.
After the washing steps were repeated, the signal was detected
with an enhanced chemiluminescence reagent. Immunoblots
were developed using a film automatic processor (SRX-101,
KonicaMinolta Medical), and films were scanned with 600-dpi
resolution on a scanner (PowerLook 1000, UMAX).
For the detection of KS-WNK1, kidney tissue was homoge-
nized in lysis buffer containing 250 mM sucrose, 10 mM tri-
ethanolamine, 1 protease inhibitors (Roche), 50 mM
sodium fluoride, 10 mM sodium pyrophosphate, and 1 mM
sodium orthovanadate.
Protein samples were subjected to polyacrylamide gel
electrophoresis and then transferred to PVDF membranes
for 2 h at 10 mV. Membranes were blocked for 2 h in 10%
nonfat dry milk dissolved in TBS-T solution (2 mM Tris-HCl,
150mMNaCl, and 0.2% Tween 20, pH 7.5).
Membranes were incubated overnight with the indicated
antibodies diluted in 5% nonfat dry milk in TBS-T, followed
by incubation for 1 h at room temperature with HRP-conju-
gated secondary antibodies diluted in 5% nonfat dry milk in
TBS-T. After the incubation, membranes were washed six
times for 10 min with TBS-T. For signal detection by chemi-
luminescence, Luminata Forte Western HRP substrate
(Merck Millipore) was used, and LI-COR equipment was
used to perform the reading.
The following antibodies were used. Rabbit anti-WNK4
(1:4,000) was a gift from David Ellison (Oregon Health &
Science University) (16). For WNK1 detection, we used com-
mercially available rabbit anti-WNK1 antibody from Bethyl
Laboratories (1:1,000, A301-515A, pan-WNK1). The following
antibodies were raised in the sheep and affinity purified on
the appropriate antigen by the Division of Signal Transduction
Therapy Unit of the University of Dundee: WNK4 total anti-
body (S064B, second bleed, raised against residues 1,2211,243
of human WNK4), NCC phospho-Thr60 antibody (S995B, resi-
dues 54–66 of human NCC phosphorylated at Thr60,
RTFGYNpTIDVVPT), NCC total antibody (S965B, residues
906–925 of human NCC, CHTKRFEDM-IAPFRLNDGFKD),
SPAK NH2-terminal antibody (S668D, raised against residues
276 of mouse SPAK), oxidative stress response-1 (OSR1)
mouse antibody (S149C, residues 389–408 of mouse OSR1,
SAHLPQPAGQMPTQPAQVSL), SPAK/OSR1 (S motif) phos-
pho-Ser373/Ser325 antibody [S670B, raised against residues
367–379 of human SPAK, RRVPGS(S)GHLHKT, which is
highly similar to residues 319–331 of human OSR1, in which
the sequence is RRVPGS(S)GRLHKT]. a-Epithelial Naþ
channel (ENaC) antibody was kindly provided by Land (17);
p44/42 MAPK (Erk1/2) antibody (3062) was purchased from
Cell Signaling Technology. Secondary antibodies coupled to
HRP used for immunoblot analysis were obtained from
Pierce. All antibodies used and their corresponding validation
studies are cited in Supplemental Table S1; see https://doi.
org/10.6084/m9.figshare.13721797).
Immunofluorescent Staining of Mouse Kidney Sections
Harvested mouse kidneys were immersion fixed in fresh
4% (w/v) formaldehyde-PBS (pH 6.9) for 16 h at 37C, washed
three times in PBS, and stored at 4C until paraffin embed-
ded. Sections (5 mm) were deparaffinized in Histoclear
(National Diagnostics) and rehydrated in graded methanol
steps. An antigen retrieval step was performed with R-
Universal buffer in the 2100 antigen retriever for a single
heat-pressure cycle (Aptum Biologics). Sections were perme-
abilized with 0.05% (v/v) Triton X-100-PBS for 20 min and
blocked for 1 h at 37C with 2% (v/v) donkey serum in 0.05%
(v/v) Triton X-100-PBS. Primary antibodies were incubated
overnight for 16 h at 4C at the following concentrations
diluted in 1% (v/v) donkey serum in 0.05% (v/v) Triton X-100-
PBS: 2 mg/mL for total SPAK and phospho-SPAK S373 and
anti-a-ENaC (Novus Biologicals, 1:500). Phospho-specific anti-
bodies included the addition of 10 μg/mL of the nonphospho-
peptide used to raise the antibody per 2 mg/mL of antibody
used. Negative controls omitted the primary antibody and
were processed in parallel. Slides were then washed for 20
min in 0.05% (v/v) Triton X-100-PBS and incubated in sec-
ondary antibody for 1 h at 37C. Preabsorbed donkey IgG-con-
jugated Alexa Fluor 488, 633, and 647 secondary antibodies
(Life Technologies/Abcam) were used at 1:200 diluted in 1%
(v/v) donkey serum in 0.05% (v/v) Triton X-100-PBS for im-
munofluorescent labeling. Slides were washed as above, coun-
terstained using Sytox orange nucleic acid stain (S11368, Life
Technologies), mounted using Prolong gold antifade (P36930,
Life Technologies), and shielded from light.
Mutagenesis and Constructs
Rat NCC, human WNK4-Flag, human L-WNK1-D11-c-Myc,
and human KS-WNK1-D11-c-Myc have been previously
described (12, 18, 19). KS-WNK1-D4a, KS-WNK1-2CxS (KS-
2CxS), KS-WNK1-6CxS (KS-6CxS), KS-WNK1-5Q (KS-5Q),
KS-WNK1-V11A, KS-WNK1-F12A, KS-WNK1-V13A, KS-WNK1-
I14A, and KS-WNK1-I15A were made from KS-WNK1-D11
using the QuikChange mutagenesis system (Stratagene). All
modifications were confirmed by DNA sequencing. cRNA
was made from linearized cDNA using the T7 RNA polymer-
ase mMESSAGE kit (Ambion). The KLHL3-Flag clone was a
gift from Richard P. Lifton (Rockefeller University). The
open reading frame was subcloned into a pGEMHE vector.
Functional Expression of NCC
Oocytes were extracted in clusters from adult female X.
laevis frogs anesthetized by submerging them in 0.17%
Tricaine. Oocytes were incubated with collagenase type 2 (3
mg/mL) eluted in Ca2þ -free ND-96 (96 mMNaCl, 2 mM KCl,
1.0 mM MgCl2, and 5 mM HEPES, pH 7.4) for 1.5 h, washed
three times with Ca2þ -free ND-96, and incubated again with
collagenase type 2 for 1.5 h. Oocytes were washed with ND-
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96 solution (96.0 mM NaCl, 2.0 mM KCl, 1.8 mM CaCl2, 1.0
mM MgCl2, and 5.0 mM HEPES, pH 7.4) three times and
incubated overnight at 16C.
Oocytes were injected with 20 ng of each of the indi-
cated cRNAs and then incubated at 16C for 48 h in ND-
96 before protein extraction for Western blot analysis or
72 h before transport experiments. MG132 (100 mM) was
added to the media 16 h before protein extraction in the
described cases.
Consent for the Performance of Animal Experiments
The use of X. laevis oocytes as well as wild-type and trans-
genic mice were approved by Institutional Animal Care and
Use Committee of the Instituto Nacional de Ciencias
Medicas y Nutricion Salvador Zubiran and in accordance
with regulations set by the Universities of Cambridge and
Dundee and the United Kingdom Home Office. Only male
mice at 12–16 wk old were used.
Western Blot Analysis of X. laevisOocyte Proteins
Twenty oocytes per experimental group were collected,
and samples were extracted using 5 mL/oocyte of lysis buffer
containing 50 mM Tris-HCl (pH 7.5), 1 mM EGTA, 1 mM
EDTA, 50 mM sodium fluoride, 10 mM sodium pyrophos-
phate, 1 mM sodium orthovanadate, 1% (w/v) Nonidet P-40,
0.27 M sucrose, and protease inhibitors (Complete tablets,
Roche).
Western blots were performed as described above. The
antibody concentrations used were anti-Flag 1:5,000
(Sigma), anti-Myc 1:1,000 (Sigma), and anti-actin 1:2,500
(Santa Cruz Biotechnology). Densitometric analysis was per-
formed using ImageStudioLite software.
Transport Assays
NCC activity was evaluated using the radioactive tracer
22Naþ (Perkin Elmer Life Sciences). Oocytes were injected as
previously described; 72 h later, 15 oocytes per group were
incubated at room temperature for 30 min in Cl-free ND-96
medium [containing (in mM) 96 sodium isethionate, 2 potas-
sium gluconate, 1.8 calcium gluconate, 1 magnesium gluco-
nate, and 5 HEPES, pH 7.4] containing 1 mM ouabain, 100
mM amiloride, and 100 mMbumetanide in the presence or ab-
sence of 100 mM trichlormethiazide. Oocytes were trans-
ferred to Kþ -free uptake medium [containing (in mM) 40
NaCl, 56 NMDG-Cl, 1.8 CaCl2, 1 MgCl2, and 5 HEPES, pH 7.4]
with ouabain, amiloride, and bumetanide with or without
trichlormethiazide and with 0.5 μCi of 22Naþ for 60 min at
32C. Oocytes were washed five times in an ice-cold radioac-
tive-free medium and placed in individual tubes with 1%
SDS. After lysis scintillation counting, liquid (ecolume, MP
Biomedicals) was added.
Statistical Analysis
In experiments with n  3, statistical significance was cal-
culated with one-way ANOVA with multiple comparisons
using GraphPad Prism 8.4.3. Significance was defined as P 
0.05. Results are presented asmeans ± SEM.
RESULTS
Generation and Characterization of a New Strain of
KLHL3 Knockin Mice
KLHL3 knockin mice carrying the FHHt mutation R528H
that prevents binding to WNK kinases (20, 21) were gener-
ated by TaconicArtemis (http://www.taconic.com/wmspage.
cfm?parm1=1453).
Phenotypic characterization under basal conditions
showed that the mice displayed the expected FHHt-like phe-
notype with hyperkalemia, metabolic acidosis, and hyper-
chloremia (Table 1). The abundance and phosphorylation of
relevant renal transporters and regulatory proteins were also
studied. As previously reported for a KLHL3þ /R528H strain
generated by Susa and collaborators (22), higher WNK4 and
NCC expression levels as well as higher NCC (Thr60) and
SPAK (Ser373) phosphorylation levels were observed in
KLHL3þ /R528H mice compared with wild-type mice. These
differences were more dramatic in KLHL3R528H/R528H mice
(Fig. 1). In homozygotes, SPAK and OSR1 expression levels
were also higher than in wild-type mice. Additionally, in
contrast to what was reported by Susa et al., a clear decrease
in the abundance of the full-length and cleaved forms
of a-ENaC was observed in both KLHL3þ /R528H and
KLHL3R528H/R528Hmicemade for this study. This finding was
corroborated by immunofluorescent staining of kidney sec-
tions (Fig. 2). Finally, in sections stained with SPAK and
phospho-SPAK (Ser373) antibodies, a punctate signal was
observed in the cytoplasm of some cortical tubular cells of
KLHL3þ /R528H and KLHL3R528H/R528H mice that contrasted
with the apical signal observed in wild-type mice. In the
medullary portion, an apical expression pattern was
observed in some tubules of wild-type and mutant mice, and
this signal intensity was higher inmutant mice.
KS-WNK1 Is Highly Sensitive to CUL3-KLHL3 E3 Ligase
Complex-Mediated Degradation in Vivo
To analyze the effect of the KLHL3-R528Hmutation onWNK1
expression, we used an antibody directed against a COOH-termi-
Table 1. Serum electrolytes of wild-type, KLHL3þ /R528H, and KLHL3R528H/R528H mice
KLHL3þ /þ KLHL3þ /R528H KLHL3R528H/R528H
Naþ , mM 146.6 ± 1.06 (n = 17) 147.3 ± 0.45 (n = 28) 148.5 ± 0.77 (n = 16)
Kþ , mM 4.63 ± 0.09 (n = 18) 5.40 ± 0.1 (n = 28) 5.56 ± 0.13 (n = 16)
Cl, mM 115.3 ± 1.46 (n = 17) 123.8 ± 1.94 (n = 24) 123.3 ± 2.03 (n = 14)
Ca2þ , mM 2.21 ± 0.05 (n = 4) 2.28 ± 0.05 (n = 5) 2.36 ± 0.09 (n = 5)
pH 7.32 ± 0.03 (n = 6) ND 7.18 ± 0.03 (n = 3)
Data are means ± SE; n represents the number of mice included in the analyses. KLHL3, Kelch-like protein 3. P < 0.05 versus wild-
type mice.
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nal epitope of the protein that can recognize both L-WNK1 and
KS-WNK1 (pan-WNK1 antibody). Given that several bands were
observed in the blots performed with this antibody, in order to
identify the band corresponding to KS-WNK1, we included in
these experiments lysates from KS-WNK1 knockout mice [KS-
WNK1/, a kind gift of Hadchouel (15), INSERM Paris] and
KLHL3R528H/R528H;KS-WNK1/ doublemutants.
Interestingly, we observed no band at the expected size for
KS-WNK1 in wild-type mice, but a robust band of this size was
observed in KLHL3R528H/R528H mice (Fig. 3). Its absence in
Figure 1. Kelch-like protein 3 (KLHL3)þ /R528H
and KLHL3R528H/R528H mice display the
expected changes in the expression and
phosphorylation levels of components of
the with no lysine kinase 4 (WNK4)-
STE20/SPS1-related proline-alanine-rich
protein kinase (SPAK)/oxidative stress
response-1 (OSR1)-NaCl cotransporter
(NCC) pathway. A: total kidney extracts
from wild-type (WT), KLHL3þ /R528H [het-
erozygrous (HET)] and KLHL3R528H/R528H
[homozygous (HOM)] mice were sub-
jected to Western blot analysis with the
indicated antibodies. Each sample was
derived from a separate littermate ani-
mal. B: band intensities were quantified
using ImageJ, and the results are pre-
sented relative to the expression of
GAPDH. Increased expression of NCC
and WNK4 as well as increased phospho-
rylation of SPAK (Ser373) and NCC (Thr60)
were observed in KLHL3þ /R528H mice.
Such differences were more dramatic in
KLHL3R528H/R528H mice, in which an
increase in the expression of SPAK and
OSR1 was also observed. ENaC, epithelial
Naþ channel; ns, not significant.
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Figure 2. Immunofluorescent staining of kidney sections was performed. The primary antibodies used are indicated. Representative images from corti-
cal and medullary regions are shown. Fluorescence intensity was quantified using ImageJ, and the results are presented in the corresponding bar
graphs. ENaC, epithelial Naþ channel; KLHL3, Kelch-like protein 3; pSPAK, phospho-SPAK; SPAK, STE20/SPS1-related proline-alanine-rich protein ki-
nase; WNK1, with no lysine kinase 1.
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double-mutant mice confirmed that indeed this band corre-
sponds to KS-WNK1. These observations suggest that the KS-
WNK1 protein expression level is very low (undetectable by
Western blot) in kidneys fromwild-type mice under basal con-
ditions, which is striking given the high KS-WNK1 mRNA lev-
els that have been reported for renal tissue (11). This
observation supports, as suggested by Luis-Dit-Picard et al. (8),
that KS-WNK1 is highly sensitive to CUL3-KLHL3 E3-mediated
degradation, given the large upregulation observed in
KLHL3R528H/R528H mice in which WNK-KLHL3 binding is
impaired.
Finally, a band of higher molecular weight that may corre-
spond to L-WNK1 was observed with the pan-WNK1 antibody,
whose intensity was similar in all genotypes. We cannot rule
out, however, that this may be a nonspecific band. WNK4
expression in the kidneys from wild-type and KS-WNK1/
mice was similar, whereas, as expected, it was increased in
KLHL3R528H/R528Hmice and double-mutantmice.
Knockout of KS-WNK1 Does Not Prevent the FHHt
Phenotype of KLHL3R528H/R528H Mice
Given the striking KS-WNK1 protein upregulation that we
observed in KLHL3R528H/R528H mice, we decided to evaluate
whether this upregulation is implicated in the pathogenesis of
FHHt. Thus, we studied the phenotype of KLHL3R528H/R528H;
KS-WNK1/ mice and compared it with the phenotype of
KLHL3R528H/R528H mice. We observed that double-knockout
mice have an FHHt phenotype with serum Kþ , Cl, HCO3
,
and pH levels similar to those observed in KLHL3R528H/R528H
mice (Table 2). Thus, KS-WNK1 upregulation does not
seem to play a central role in the pathogenesis of FHHt. In
further experiments, administration of diets with altered
content of Kþ and Naþ may help to uncover phenotypic
differences. However, this was out of the scope of this
work.
KS-WNK1 and L-WNK1 Exhibit Different Sensitivity to
CUL3-KLHL3 E3-Mediated Degradation
Our preliminary data, published in Louis-Dit-Picard et
al. (8), showed that KS-WNK1 is heterologously expressed
in X. laevis oocytes and in human embryonic kidney
(HEK)-293 cells is readily degraded when coexpressed with
KLHL3. In contrast, L-WNK1 is resistant to such degrada-
tion. To further explore this phenomenon, we began by
analyzing the effect of KLHL3 coexpression on KS-WNK1
and L-WNK1-mediated activation of NCC. We microin-
jected X. laevis oocytes with NCC cRNA in the absence or
presence of L-WNK1 or KS-WNK1 cRNA with or without
KLHL3 cRNA. Three days later, thiazide-sensitive tracer
Naþ uptake was assessed. As we have previously shown
(12), both KS-WNK1 and L-WNK1 were able to increase the
activity of NCC, despite the fact that KS-WNK1 has no ki-
nase domain (Fig. 4A). Our previous work supported that
the effect of KS-WNK1 on NCC is likely due to an interac-
tion of KS-WNK1 with an endogenous WNK kinase, since
the presence of KS-WNK1 increased the phosphorylation
of SPAK and NCC, and the effect was prevented by the spe-
cific WNK inhibitor WNK463 (12). Consistent with our pre-
liminary observations (8), the effect of KS-WNK1 on NCC
was completely prevented by coinjection with KLHL3 cRNA,
whereas the effect of L-WNK1 on NCCwas not.
We then analyzed the effect of KLHL3 expression on
L-WNK1, KS-WNK1, WNK3, and WNK4 abundances. This
effect has been previously described. However, no study
has compared the effect of KLHL3 on all these WNK iso-
forms in parallel (4, 5, 21). Figure 4B shows a representative
image of such analysis. Oocytes were injected with each
WNK cRNA alone or coinjected with KLHL3 cRNA. L-
WNK1, KS-WNK1, and WNK3 expression was assessed with
anti-c-myc antibodies and WNK4 and KLHL3 with anti-
Flag antibodies. Consistent with the results shown in Fig.
4A, the presence of KLHL3 had little to no effect on the L-
WNK1 expression level, whereas the expression of KS-
WNK1 in the presence of KLHL3 was completely abrogated.
In addition, we observed that WNK3 and WNK4 exhibited
high sensitivity to CUL3-KLHL3 E3-mediated degradation.
Thus, according to the densitometric analysis (Fig. 4C), it
appears that at least in X. laevis oocytes the sensitivity of L-
WNK1 to the effect of the CUL3-KLHL3 E3 complex was sig-
nificantly lower than that observed for the other WNKs. A
similar observation has also been reported in HEK-293 cells
by Louis-Dit-Picard et al. (8).
The Unique KS-WNK1 Segment Encoded by Exon 4a Is
Involved in the Sensitivity to the CUL3-KLHL3 E3 Ligase
Complex
L-WNK1 and KS-WNK1 have different NH2-terminal por-
tions but are identical from the beginning of the segment
encoded by exon 5 until the end of the protein. Thus, they
Figure 3. Kidney-specific with no lysine kinase (WNK)1 (KS-WNK1) protein
levels are undetectable in kidney tissue of wild-type mice but are high in
mice in which cullin 3-Kelch-like protein 3 (KLHL3) E3-mediated degrada-
tion is prevented. Total kidney lysates from KLHL3R528H/R528H mice, KS-
WNK1/ mice, and double mutants (KLHL3R528H/R528H; KS-WNK1/ mice)
were analyzed byWestern blot to assess the expression of WNK1 isoforms
(as measured by the pan-WNK1 antibody). The robust band observed in
KLHL3R528H/R528H mice (arrow) that was absent in wild-type mice corre-
sponds to KS-WNK1, as corroborated by its absence in the double
mutants. The WNK4 blot is presented at the bottom. The expected
increase in WNK4 expression was observed in KLHL3R528H/R528H samples
and in KLHL3R528H/R528H; KS-WNK1/ mice.
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both contain the acidic motif (EPEEPEADQHQ) that medi-
ates interactions with KLHL3 (Supplemental Fig. S2; see
https://doi.org/10.6084/m9.figshare.13721794).
The first 30-amino acid residues of KS-WNK1 are unique
to this isoform because they are encoded by exon 4a,
which is not included in the L-WNK1 transcript. Exon 4a is
highly conserved across evolution since its amino acid
sequence is almost identical from coelacanths to humans
(13), suggesting that it plays a key role in species that have
evolved a renal tubule. This segment has been shown to be
key for the formation of KS-WNK1-dependent WNK bodies
(13). Thus, to evaluate its effect on KS-WNK1 activity and
CUL3-KLHL3 E3-mediated degradation, we generated the
KS-WNK1-D4a clone that lacks this fragment. We assessed
its ability to activate NCC and its sensitivity to degradation
promoted by CUL3-KLHL3 E3. As previously described
(12), the absence of the 4a fragment prevents the positive
effect of KS-WNK1 on NCC activity (Fig. 5A). Interestingly,
this modification prevented KS-WNK1 functionality and
also prevented its degradation, as demonstrated by the
representative blot shown in Fig. 5B and the densitometric
analysis shown in Fig. 5C. We observed a mild protective
effect of the proteasome inhibitor MG132 against CUL3-
KLHL3-RING-induced degradation of KS-WNK1, suggest-
ing that other pathways may also be involved in degrada-
tion (Fig. 5B).
The Cysteines in Region 4a Are Important for KS-WNK1
Function but Not for Its CUL3-KLHL3 E3-Mediated
Degradation
Boyd-Shiwarski et al. (13) have previously analyzed the
degree of conservation of individual residues within the 4a
segment and have identified a cluster of conserved cysteines
and a cluster of conserved hydrophobic residues (Fig. 6A).
Mutagenic analysis led them to conclude that these clusters,
which they termed the “cysteine-rich hydrophobic motif,”
are key for the formation of KS-WNK1-dependent WNK
bodies. Thus, we decided to evaluate their role on KS-WNK1-
dependent NCC activation and sensitivity to CUL3-KLHL3
E3-induced degradation.
We first decided to analyze the role of conserved cysteines.
For this purpose, we generated a clone with the six con-
served cysteines mutated to serine (KS-6CxS mutant) and a
clone in which only the outer two cysteines were mutated to
serine (KS-2CxS mutant; Fig. 6A). According to the data by
Boyd-Shiwarski et al. (13), the KS-6CxS mutation prevents
the formation of WNK bodies, but the KS-2CxS mutation
only partially does so.
We injected oocytes with NCC and wild-type KS-WNK1 or
mutants KS-6CxS or KS-2CxS and treated them with or with-
out MG132 to evaluate their function and degradation. We
observed that the ability of the KS-6CxS mutant to activate
NCC was completely abrogated, whereas that of the KS-2CxS
mutant was only partially impaired (Fig. 6B). Regarding
CUL3-KLHL3 E3-mediated degradation, we observed that
both mutants were degraded in the presence of KLHL3, sug-
gesting that, although the whole exon 4a seems to be impor-
tant in conferring sensitivity to CUL3-KLHL3 E3-mediated
degradation, the cysteine residues are not involved (Fig. 6, C
andD).
The Cluster of Hydrophobic Residues in the 4a Segment
of KS-WNK1 Are Key for NCC Activation and Confers KS-
WNK1 Sensitivity to CUL3-KLHL3 E3-Mediated
Degradation
We next analyzed the role of the cluster of hydrophobic
residues on KS-WNK1 ability to activate NCC and on its sen-
sitivity to CUL3-KLHL3 E3-mediated degradation. This clus-
ter includes the five hydrophobic amino acid residues
between the positions 11 and 15 (valine, phenylalanine, va-
line, isoleucine, and isoleucine; Fig. 6A). We generated a
clone in which these five residues were mutated to gluta-
mine (KS-5Q mutant). We decided to mutate these residues
to glutamine given that Boyd-Shiwarski et al. (13) used this
strategy to substitute the hydrophobic residues for hydro-
philic ones and showed that these mutations prevented
WNK body formation. Thus, we evaluated if the same muta-
tions can also affect kidney-specific function and KLHL3-
induced degradation. We observed that the ability of this
mutant to activate NCC was completely impaired (Fig. 7A).
Interestingly, however, we observed that this mutant was
insensitive to CUL3-KLHL3 E3-induced degradation (Fig. 7,
B and C).
Valine 11 and Valine 13 of KS-WNK1 Are Relevant for Its
CUL3-KLHL3 E3-Mediated Degradation
To evaluate the role of individual residues within the
hydrophobic cluster on KS-WNK1 activity and degradation,
we generated the five single residue mutants and studied
them in the oocyte system as performed for the other
mutants. For the individual mutants, we decided to mutate
each of the hydrophobic amino acid residues to alanine to
explore whether the sole absence of the hydrophobic lateral
chain is sufficient to produce these effects. We observed that
the V11A mutant was unable to activate NCC and that this
function was significantly reduced for the V13A mutant. For
Table 2. Serum electrolytes of wild-type, KLHL3R528H/R528H, KS-WNK1/, and double-mutant mice
KLHL3þ /þ ; KS-WNK1þ /þ KLHL3R528H/R528H; KS-WNK1þ /þ KLHL3þ /þ ; KS-WNK1/ KLHL3R528H/R528H; KS-WNK1/
Naþ , mM 151 ± 0.56 (n = 6) 152 ± 0.56 (n = 6) 150 ± 0.61 (n = 6) 153 ± 0.58 (n = 6)
Kþ , mM 4.5 ± 0.16 (n = 6) 5.1 ± 0.10 (n = 6) 4.7 ± 0.12 (n = 6) 5.0 ± 0.12 (n = 6)
Cl, mM 118 ± 0.61 (n = 6) 123 ± 0.22 (n = 6) 118 ± 0.53 (n = 6) 122 ± 0.40 (n = 6)
Ca2þ , mM 4.2 ± 0.3 (n = 6) 4.5 ± 0.06 (n = 6) 4.2 ± 0.12 (n = 6) 4.3 ± 0.04 (n = 6)
pH 7.3 ± 0.03 (n = 6) 7.2 ± 0.01 (n = 6) 7.3 ± 0.02 (n = 6) 7.2 ± 0.01 (n = 6)
HCO3
, mM 20 ± 0.76 (n = 6) 14 ± 0.42 (n = 6) 17 ± 0.36 (n = 6) 15 ± 0.52 (n = 6)
Data are means ± SE; n represents the number of mice included in the analyses. KLHL3, Kelch-like protein 3; WNK1, with no lysine ki-
nase 1. P < 0.05 versus wild-type mice.
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the remaining three mutants, this function was only
slightly reduced (Fig. 8A). CUL3-KLHL3 E3-mediated deg-
radation was impaired for the V11A and V13A mutants (Fig.
8, B and C), suggesting that these residues may participate
in conferring the sensitivity to CUL3-KLHL3E3-mediated
degradation.
KS-WNK1 Protein Expression Is Upregulated in Kidneys
of Mice Maintained on Low-Kþ Diet
Ishizawa et al. (23) recently showed that phosphorylation
of KLHL3 in a residue located within the substrate-binding
domain is upregulated in mice that are maintained on a low-




Figure 4. Kidney-specific with no lysine kinase (WNK)1 (KS-WNK1), WNK3,
and WNK4, but not full-length WNK1 (L-WNK1), are degraded when coex-
pressed with Kelch-like protein 3 (KLHL3) in oocytes. A: thiazide-sensitive
22Naþ uptake was assessed in Xenopus laevis oocytes injected with the
indicated cRNAs. Uptake values observed in the control group (NCC only)
were set to 100%, and the other groups were normalized accordingly.
While both L-WNK1 and KS-WNK1 increased Naþ uptake, KLHL3 coex-
pression prevented NaCl cotransporter (NCC) activation by KS-WNK1 but
not by L-WNK1. Dots represent uptake values for individual oocytes. At
least three independent experiments were performed with >10 oocytes
per group (P< 0.0001 vs. NCC; three points outside graphic limits). B:
representative Western blots showing the effect of KLHL3 coexpression
on L-WNK1, KS-WNK1, WNK3, and WNK4 levels. Oocytes were injected
with cRNAs encoding for c-Myc-tagged L-WNK1, KS-WNK1, or WNK3 or
Flag-tagged WNK4 with or without Flag-tagged KLHL3. All kinases except
L-WNK1 were degraded in the presence of KLHL3. C: densitometric analy-
sis of the Western blots presented in B. Two independent experiments
were performed with similar results. c-Myc-tagged L-WNK1, KS-WNK1, or
WNK3 or Flag-tagged WNK4 were normalized to 100% and compared




Figure 5. The segment encoded by exon 4a in kidney-specific with no ly-
sine kinase 1 (KS-WNK1) is needed to activate NaCl cotransporter (NCC)
and to be targeted for degradation by cullin-3 (CUL3)–Kelch-like protein 3
(KLHL3) E3. A: thiazide-sensitive Naþ uptake of NCC cRNA-injected
oocytes was set to 100%, and uptake values of additional groups were
normalized accordingly. KS-WNK1 coexpression increased NCC activity,
but the KS-WNK1-D4a mutant failed to activate (n = 3 transport assays,
P < 0.0001 vs. NCC; one point outside graphic limits). B: representa-
tive Western blots showing KS-WNK1 and KS-WNK1-D4a expression in the
absence or presence of KLHL3. CUL3-KLHL3 E3-induced degradation of
KS-WNK1 is observed regardless of proteosome inhibition, whereas KS-
WNK1-D4a is expressed but resistant to CUL3-KLHL3 E3-induced degra-
dation. C: densitometric analysis of the Western blots presented in B.
Results from four different experiments were included. Expression of KS-
WNK1 or KS-WNK1-D4a in the absence of KLHL3 were arbitrarily set to
100% and compared with expression levels observed in the presence of
KLHL3 (n = 4 Western blots, P> 0.001 vs. control without KLHL3).
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ofWNK4. Thus, to evaluate whether Kþ restriction is a possi-
ble physiological stimuli for induction of KS-WNK1 expres-
sion, wild-type, and KLHL3þ /R528H mice were placed on
low-Kþ diet for 7 days and then euthanized for renal tissue
collection. Kidney lysates were prepared and analyzed by
Western blot analysis with pan-WNK1 and WNK4 antibod-
ies (Fig. 9).
The band corresponding to KS-WNK1 was only barely
observed in samples from KLHL3þ /R528Hmice (Fig. 9), in con-
trast to what we previously observed with KLHL3R528H/R528H
mouse samples (Fig. 3). This suggests that the residual activity
of the CUL3-KLHL3 E3 complex present in heterozygous mice
is sufficient to almost entirely degrade KS-WNK1. A more ro-
bust band was observed in samples from wild-type and
KLHL3þ /R528H mice maintained on the low-Kþ diet, showing
that indeed KS-WNK1 expression is induced under conditions
of dietary Kþ restriction. WNK4 upregulation was also
observed, as previously reported (23).
DISCUSSION
In the present study, we show that KS-WNK1 is more sen-
sitive to CUL3-KLHL3 E3-mediated degradation than L-
WNK1, and we began to explore the elements of their pri-
mary sequence that are responsible for this difference. Given
that the known binding site for KLHL3 inWNK kinases is the
acidic motif, the observation is puzzling as both proteins
present the exact same binding site. Interestingly, we
observed that removal of the unique sequence of KS-WNK1
encoded by exon 4a decreases its sensitivity to CUL3–KLHL3
E3-mediated degradation. This shows that targeting by
KLHL3 of the COOH-terminal segment of WNK1 (comprising
the sequence encoded from exon 5 until the end that
includes the acidic motif) is not efficient unless this 30-
amino acid residue segment is present. We also showed that
this segment is critical for the ability of KS-WNK1 to activate
NCC. Other works also support the key role of exon 4a for
KS-WNK1 function. For instance, Argaiz et al. (12) showed
that the ability of KS-WNK1 to activate NCC by promoting
WNK4 phosphorylation is impaired by the removal of this
segment, although KS-WNK1 binding to WNK4 was not
affected, and Boyd-Shiwarski et al. (13) showed that exon 4a
is necessary for the KS-WNK1-dependent formation of WNK
bodies.
Interestingly, the analysis of the effects of mutation of cer-













Figure 6.Mutation of the six conserved cysteines encoded in exon 4a impairs the ability of kidney-specific with no lysine kinase 1 (KS-WNK1) to activate
NaCl cotransporter (NCC) but does not prevent cullin-3 (CUL3)-Kelch-like protein 3 (KLHL3) E3-induced degradation. A: amino acid sequence encoded
by exon 4a. Different KS-WNK1 mutants were generated for this work with variations in the sequence of this region. The modifications introduced in
each mutant are indicated. B: NCC was coexpressed in oocytes with KS-WNK1, KS-6CxS (in which all six cysteines were mutated to serine), or KS-2CxS
(in which the two peripheral cysteines were mutated to serine). Thiazide-sensitive Naþ uptake of NCC-expressing oocytes was set to 100% and com-
pared with all other groups, which were normalized accordingly. KS-WNK1-6CxS did not activate NCC, whereas KS-WNK1-2CxS did activate NCC, albeit
at a lower level than wild-type KS-WNK1 (n = 3 transport assays, P< 0.0001 vs. NCC; 3 points outside graphic limits). C: representative Western blots
showing the expression of KS-WNK1-6CxS and KS-WNK1-2CxS. Both mutant proteins are targeted for degradation by CUL3-KLHL3 E3, whereas treat-
ment with MG132 could prevent KS-WNK1-2CxS degradation. D: compiled results of densitometric analysis from at least two different Western blot
experiments like that presented in (B). Expression levels of KS-WNK1, KS-WNK1-6CxS, and KS-WNK1-2CxS in the absence of KLHL3 were normalized to
100% and compared with groups expressing KLHL3 (n = 24 Western blots, P< 0.01 and P< 0.0001 vs. control without KLHL3).
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these modifications alter KS-WNK1 ability to activate NCC,
but not its targeting by KLHL3, whereas those that affect
KLHL3 targeting also affect the ability to activate NCC. Thus,
although the same segment is key to define the sensitivity to
CUL3-KLHL3 E3 and the ability of KS-WNK1 to activate NCC,
these properties can be dissociated, suggesting that they are




Figure 7. Mutation of the five conserved hydrophobic residues encoded
in exon 4a impairs the ability of kidney-specific with no lysine kinase 1 (KS-
WNK1) to activate NaCl cotransporter (NCC) and prevent cullin-3-Kelch-
like protein 3 (KLHL3) E3-induced degradation. A: NCC was coexpressed
in oocytes with KS-WNK1 or KS-5Q (in which all five hydrophobic residues
were mutated to glutamine), and thiazide-sensitive Naþ uptake was
assessed. Uptake levels observed for NCC-expressing oocytes were
normalized to 100% and compared with those observed for groups
expressing KS-WNK1 and KS-5Q. The strong activation of NCC induced
by KS-WNK1 was not observed in the KS-5Q mutant (n = 5 transport assays,
P < 0.0001 vs. NCC; 2 points outside graphic limits). B: representative
Western blots showing the expression of KS-WNK1 and KS-5Q. KS-WNK1
was degraded in the presence of KLHL3, whereas KS-5Q was not
degraded. Treatment with MG132 increased KS-5Q expression, probably
by impairing degradation even more. C: compiled results of densitometric
analysis from three different experiments like that presented in B.
Expression levels of KS-WNK1 and KS-5Q in the absence of KLHL3 were
normalized to 100% and compared with those observed in groups express-




Figure 8. Mutation of valine 11 or valine 13 located in the hydrophobic
motif of exon 4a impairs the ability of kidney-specific with no lysine ki-
nase 1 (KS-WNK1) to activate NaCl cotransporter (NCC) and cullin-3-
Kelch-like protein 3 (KLHL3) E3-induced degradation of KS-WNK1. A:
NCC was coexpressed in oocytes with KS-WNK1 or with KS-WNK1
mutants containing one of the following single amino acid substitutions:
V11A, F12A, V13A, I14A, or I15A. Uptake levels observed for NCC-
expressing oocytes were normalized to 100% and compared with those
observed for groups expressing KS-WNK1 mutants. All mutants except KS-
WNK1-V11A were capable of activating NCC (n = 35 transport assays, P<
0.05, P< 0.001, and P< 0.0001 vs. NCC; 16 points outside graphic
limits). B: representative Western blots showing the expression of KS-WNK1
and of each single-residue mutant in the absence or presence of KLHL3.
Compared with wild-type (WT) KS-WNK1, there was significantly less degra-
dation of the V11A and V13A mutants in the presence of KLHL3. Other
mutants degraded similarly to the WT. C: compiled results of densitometric
analysis from at least five different experiments like that presented in B.
Expression levels of KS-WNK1 and single-residue mutants in the absence of
KLHL3 were normalized to 100%. Degradation of single-residue mutants
were compared with WT KS-WNK1 in the presence of KLHL3 (n = 58
Western blots, P< 0.05 and P< 0.001 vs. control with KLHL3).
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Substitution of either one of two specific residues within
the conserved hydrophobic motif in exon 4a was enough to
prevent CUL3-KLHL3 E3-mediated degradation of KS-WNK1.
The mechanisms underlying 4a segment’s role on KS-WNK1
activity and sensitivity to targeting by KLHL3 remain as open
questions for future studies. Possible mechanisms are, for
example, that this segment may be involved in establishing
key interactions or that perhaps it could be a determinant to
achieve a specific conformational state of the protein.
Our data suggest that KS-WNK1 is also highly sensitive to
CUL3-KLHL3 E3-mediated degradation in vivo. Vidal-Petiot
et al. (11) reported that KS-WNK1 mRNA levels are high in
the kidney (higher than L-WNK1 mRNA levels). Despite this,
we were unable to detect KS-WNK1 protein in kidney lysates
from wild-type mice by Western blot analysis. However, ro-
bust KS-WNK1 protein expression was detected in lysates
from KLHL3R528H/R528H mice in which KLHL3-WNK binding
is impaired. Thus, the low protein expression observed in
wild-type mice may result from a high degradation rate of
KS-WNK1. The physiological significance of this observation
remains to be determined. Analogous biological phenomena
have been described. For example, the ubiquitous transcrip-
tion factor hypoxia-inducible factor-1a (HIF-1a) is normally
undetectable at the protein level due to highly active protea-
somal degradation that is dependent on the presence of O2
(24). HIF-1a is marked for degradation by a cullin–RING E3
ligase complex in which the von Hippel-Lindau (VHL) tumor
suppressor protein acts as the substrate recognition element.
VHL can only recognize HIF-1a when it is hydroxylated at
two proline residues, and hydroxylation is dependent on the
activity of prolyl-hydroxylases that are activated in the pres-
ence of O2. Thus, in conditions of hypoxia, hydroxylation is
prevented and HIF-1a expression is rapidly induced, as well
as expression of its target genes.
In the case of KS-WNK1, the physiological stimuli that can
upregulate its expression remain to be elucidated. We show
here, however, that one of these stimuli is dietary Kþ restric-
tion. Ishizawa et al. (23) have shown that KLHL3 phosphoryl-
ation in the substrate recognition domain is induced by
low-Kþ intake in mice. Thus, low-Kþ -induced phospho-
rylation of KLHL3 may underlie the observed upregulation
of KS-WNK1 in mice on a low-Kþ diet. This observation is
in line with the fact that the formation of WNK bodies,
which is induced by low-Kþ intake, requires the presence
of KS-WNK1, suggesting that indeed the DCT response to
low-Kþ intake involves KS-WNK1 upregulation due to KLHL3
inhibition by phosphorylation. This agrees with the observa-
tion that WNK bodies are present in KLHL3R528H/R528H mice
(Fig. 2) but not in mice with FHHt caused by mutations in
WNK4 (14).
The physiological role of KS-WNK1 is currently a very con-
troversial issue. However, knowledge of the conditions in
which KS-WNK1 protein is expressed in the DCT may help
guide experiments to uncover this physiological role. In the
present work, we show that despite the high KS-WNK1 pro-
tein upregulation observed in FHHt mice due to a mutation
in KLHL3, KS-WNK1 is not essential to develop the FHHt
phenotype. That is, WNK4 overexpression appears to be
sufficient to produce the disease, consistent with prior
results (25).
Different lines of evidence obtained from a diversity of
transgenic mouse models suggest that the WNK1 isoform
expressed in the DCT is KS-WNK1 and that L-WNK1 is not
normally present (1). Absence of WNK4 expression com-
pletely impairs the phosphorylation and activity of NCC (26),
demonstrating that WNK4 absence cannot be compensated
by L-WNK1 activity. Additionally, in KLHL3R528H/R528H mice,
expression of both L-WNK1 and WNK4 is increased but the
FHHt phenotype is completely abrogated by elimination of
WNK4, although L-WNK1 remains upregulated, strongly sug-
gesting that L-WNK1 is not present in the DCT (25). Thomson
et al. (14) have shown that, within the large WNK bodies
observed in WNK4 knockout mice, no active WNK1 is pres-
ent, as indicated by the lack of signal obtained with the pT-
loop WNK antibody, supporting that the WNK1 product in
the WNK bodies is KS-WNK1, not L-WNK1. Finally, it has
been demonstrated that intronic WNK1 deletions responsi-
ble for FHHt cause ectopic expression of L-WNK1 in the DCT
(7), and this is the unique situation in which the absence of
WNK4 does not result in NCC downregulation (18). Thus,
given that L-WNK1 activity is less sensitive to inhibition by
Figure 9. Renal kidney-specific with no lysine kinase 1 (KS-WNK1) expres-
sion is induced by a low-Kþ diet (LKD). Total kidney lysates from wild-type
(WT) and Kelch-like protein 3 (KLHL3)þ /R528H mice maintained on a nor-
mal-Kþ diet (NKD) or LKD were analyzed by Western blot to assess the
expression of KS-WNK1. Compared with WT mice, moderately higher
expression was observed in KLHL3þ /R528H mice. In addition, a robust
increase in KS-WNK1 expression was observed in WT mice but also in
KLHL3þ /R528H mice, suggesting that KLHL3-targeted degradation was fur-
ther affected under this condition. Results of quantitation of the band cor-
responding to KS-WNK1 are shown at the bottom. Band intensity values of
mice on a NKD were normalized to 100%. A WNK4 blot is also shown. The
expected increase in WNK4 expression was observed in KLHL3þ /R528H
samples. Expression was further increased when mice were placed on a
LKD, as previously reported (10). n = 9 for WT mice on the LKD and NKD, n =
3 for KLHL3þ /R528H mice on the NKD, and n = 4 for KLHL3þ /R528H mice on
the LKD. P< 0.05 versus the NKD. WNK1, with no lysine kinase 1.
KS-WNK1 SENSITIVITY TO KLHL3
AJP-Renal Physiol  doi:10.1152/ajprenal.00575.2020  www.ajprenal.org F745
Downloaded from journals.physiology.org/journal/ajprenal (086.178.204.091) on May 18, 2021.
Cl than WNK4 (27, 28) and less sensitive to CUL3-KLHL3
E3-induced degradation, as shown by this work, it is likely
that ectopic expression of L-WNK1 promotes higher levels of
NCC activity at any given value of intracellular Cl concen-
tration and activity level of the CUL3-KLHL3 E3 complex. In
this regard, it is noteworthy that WNK1 intronic deletions
cause FHHt even in the absence of WNK4 (18), supporting
that if L-WNK1 is expressed in the DCT, the presence of
WNK4 would be irrelevant. In future work, it would be inter-
esting to establish how low-Kþ interferes with CUL3-KLHL3
E3-mediated degradation of KS-WNK1.
Finally, as mentioned in the INTRODUCTION, Louis-Dit-
Picard et al. (8) have shown that humans andmice with heter-
ozygous mutations in the acidic motif of WNK1 display a mild
FHH phenotype that is easily corrected with thiazide treat-
ment in both species. They also showed that the SPAK/OSR1-
NCC pathway is upregulated in WNK1þ /delE631 mice. Thus,
they proposed that NCC upregulation is the primary defect
leading to the phenotypic alterations. Also, based on results
from in vitro experiments, they proposed that the increased
expression of KS-WNK1 in the DCT is largely responsible for
NCC upregulation as KS-WNK1 abundance is preferentially
affected by these mutations. The large WNK bodies observed
in DCT cells of these mice also support this idea, as well as the
in vitro and in vivo data presented in this work, showing that
KS-WNK1 is very sensitive to CUL3-KLHL3 E3-induced degra-
dation. However, as KS-WNK-1 activates NCC via WNK4, the
effect of an increase in KS-WNK1 may be buffered by the
amount of WNK4, causing only amild activation of NCC. This
activation is probably enough to cause slight hyperkalemia
and volume retention but not enough to produce a rise in
blood pressure.
In conclusion, our work shows, both in vivo and in vitro,
that KS-WNK1 is highly sensitive to CUL3-KLHL3 E3-
induced degradation, whereas L-WNK1 is much less sensi-
tive. The high sensitivity of KS-WNK1 seems to be due to the
presence of the unique segment encoded in exon 4a. This
segment is also key for KS-WNK1 function and its ability to
activate NCC. We propose that this exquisite sensibility of
KS-WNK1 to targeting by KLHL3 may be relevant to achieve
rapid induction of KS-WNK1 protein expression under cer-
tain conditions, one of which appears to be extracellular Kþ
depletion. The mechanisms by which exon 4a affects the ac-
tivity and sensitivity to degradation of KS-WNK1 and the role
that KS-WNK1 upregulation plays under conditions of die-
tary Kþ deprivation remain to be explored.
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